Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2007
03/15/2007US20070059721 MAGI polynucleotides, polypeptides, and antibodies
03/15/2007US20070059709 Staphylococcus aureus antibacterial target genes
03/15/2007US20070059708 Gene screen
03/15/2007US20070059706 Materials and methods relating to breast cancer classification
03/15/2007US20070059705 coated with phosphor fluoride via dispersing nanoparticle and aqueous fluoride-containing compound in deionized water, contacting mixture with aqueous solution containing soluble salts of phosphor host, absorber-emitter pair, and rare-earth metal chelator by stirring to allow precipitate
03/15/2007US20070059702 Disease related protein network
03/15/2007US20070059698 Marks as modifers of the pten pathway and methods of use
03/15/2007US20070059696 Assessment method
03/15/2007US20070059695 Sgk1 as diagnostic and therapeutic target
03/15/2007US20070059694 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1)
03/15/2007US20070059692 Array oligomer synthesis and use
03/15/2007US20070059691 Method for determining the susceptibility of a subject to infection
03/15/2007US20070059688 Gastrointestinal chemosensory receptors
03/15/2007US20070059687 Process for evaluating phagocytotic function and use thereof
03/15/2007US20070059683 Veterinary diagnostic system
03/15/2007US20070059682 Method to increase specificity and/or accuracy of lateral flow immunoassays
03/15/2007US20070059681 Method for production of bioresorable microparticles, microparticles thus obtained and use thereof
03/15/2007US20070059312 Anti-vegf antibodies
03/15/2007US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE)
03/15/2007US20070059290 Transcriptional regulation of target genes
03/15/2007US20070059272 Modulation of microbial pathogen-host cell interactions
03/15/2007US20070059217 Process for the production of biopolymer fields with real-time control
03/15/2007US20070059205 Automated micro-well plate handling device
03/15/2007US20070059204 Point of care diagnostic platform
03/15/2007US20070058171 Reflectance sensor for measuring liquid pigment preparations or solid pigmented surfaces
03/15/2007US20070057675 Oil sensor mounting structure
03/15/2007US20070056980 Nine container per tray packaging configuration and method for enhanced cooling of produce
03/15/2007US20070056873 Blistered rapid diagnostic test with incorporated moisture absorbent material
03/15/2007US20070056858 In vitro analyte sensor, and methods
03/15/2007US20070056549 Oil pan for engine
03/15/2007US20070056396 Millimetre-wave detection device for discriminating between different materials
03/15/2007US20070056374 Monitoring system
03/15/2007US20070056352 Drift compensation for an impedimetric exhaust gas sensor by variable bias voltage
03/15/2007DE212004000059U1 Schnelle Probensammel- und Analysevorrichtung Fast sample collection and analysis apparatus
03/15/2007DE202006018054U1 Diagnostisches Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/oder HIV Antigenen in humanem Probenmaterial Diagnostic test system for the simultaneous, quantitative detection of HIV1 and HIV2 antibodies and / or HIV antigens in human specimens
03/15/2007DE19533346B4 Nachweis von Antigenen und Antikörpern in einem Testmedium Detection of antigens and antibodies in a test medium
03/15/2007DE102006041016A1 Pulsoximeter`s function tester, has control unit producing input current for pulsoximeter such that distribution and variable of current produced by tester correspond to current of sensor connected to pulsoximeter
03/15/2007DE102005053299A1 High-temperature housing for semiconductor gas sensors, has connectors with shaped parts located on flat ceramic base for connecting gas sensors on ceramic base, and protective ring locked with gas-permeable cap and surrounding gas sensors
03/15/2007DE102005043612A1 Endothelium-protective perfusion apparatus, has pressure piston having large weight, where perfusion liquid sprayed from spraying device is conducted with constant pressure into hollow organ of user`s body, during opening of outlet tube
03/15/2007DE102005043113A1 Verfahren zur Bestimmung des endogenen antioxidativen Potentials von Getränken mittels ESR-Spektroskopie A method for determining the endogenous antioxidative potential of beverages by means of ESR-spectroscopy
03/15/2007DE102005042367A1 Vorrichtung und Verfahren zum Erzeugen von 3-D Bildern einer Probe Apparatus and method for generating 3-D images of a sample
03/15/2007DE102004051573B4 Verfahren zur Behandlung einer Abfallflüssigkeit in Chemischen Reaktions-Patronen und chemische Reaktions-Patrone, in der das Verfahren angewendet wird A method for treating a waste liquid in chemical reaction cartridge and chemical reaction cartridge, in which the process is applied
03/15/2007CA2849640A1 Serum bactericidal assay for n. meningitidis specific antisera
03/15/2007CA2662798A1 Antibodies as t cell receptor mimics, methods of production and uses thereof
03/15/2007CA2633499A1 Method for the determination of the stresses occurring in wood when drying
03/15/2007CA2622036A1 Targeted identification of immunogenic peptides
03/15/2007CA2621789A1 Functional in vitro immunoassay
03/15/2007CA2621666A1 Antigens for vaccination against and detection of mycoplasma suis
03/15/2007CA2621578A1 Serum bactericidal assay for n. meningitidis specific antisera
03/15/2007CA2621562A1 Methods and organisms for the growth-coupled production of succinate
03/15/2007CA2621485A1 Method for diagnosing infections utilizing surface antigens obtained without disrupting cells
03/15/2007CA2621439A1 Methods and compositions for diagnosis and immunotherapy of pollen allergy
03/15/2007CA2621352A1 Magnetic nanoparticle having fluorescent and preparation method thereof and use thereof
03/15/2007CA2621345A1 Single receptor assays for immunosuppressive drugs
03/15/2007CA2620863A1 Fire assay flux composition for the analysis of pgm and gold containing mineral samples
03/15/2007CA2620552A1 Device with a compressible matrix having a homogeneous flow profile
03/15/2007CA2561991A1 Detecting gene methylation
03/15/2007CA2558125A1 Crystal structure of a complex of integron integrase from vibrio cholerae bound to a recombination substrate
03/14/2007EP1762849A1 Method for demonstrating efficacy of a topically applied active ingredient
03/14/2007EP1762848A1 Retracting mechanism for a bio reader
03/14/2007EP1762847A2 Oil pan for automotive engines
03/14/2007EP1762846A2 Oil sensor mounting structure
03/14/2007EP1762845A2 Method and device for prediction of moisture damage and drying
03/14/2007EP1762839A1 Integrated opto-electric sensor
03/14/2007EP1762837A2 Method and measuring device for determining the CO2 concentration in a CO2-containing liquid
03/14/2007EP1762626A1 Signal amplification using a synthetic zymogen
03/14/2007EP1762623A1 Methods for producing biologically active peptide dimers
03/14/2007EP1762619A2 Multiple-tumor aberrant growth genes
03/14/2007EP1762618A1 Method for the preparation of nucleic acids from whole blood and its application in the diagnosis of TSE using real-time PCR
03/14/2007EP1762610A1 Truncated dance, dance complex and method of using these
03/14/2007EP1762243A1 Factor for regulation of neurite growth
03/14/2007EP1761879A1 Methods, systems, and software for identifying funtional biomolecules
03/14/2007EP1761822A2 A dynamic fluid control system for immersion lithography
03/14/2007EP1761785A1 Method of diagnosing lawsonia intracellularis
03/14/2007EP1761784A2 Identification of ergothioneine transporter and therapeutic uses thereof
03/14/2007EP1761783A2 Identification of compounds modifying a cellular response
03/14/2007EP1761782A2 Use of protein cbp2 as a marker for colorectal cancer
03/14/2007EP1761781A1 Use of protein rs15a as a marker for colorectal cancer
03/14/2007EP1761780A1 Use of inorganic pyrophosphatase as a marker for colorectal cancer
03/14/2007EP1761779A1 Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
03/14/2007EP1761778A2 Method for determining aggrecanase activities
03/14/2007EP1761777A1 Sepsis diagnostic test
03/14/2007EP1761776A1 Use of the receptor gpr86
03/14/2007EP1761775A1 Integrated analysis device which can be fitted to a container housing a sample to be analysed
03/14/2007EP1761774A1 Analyte detection system
03/14/2007EP1761773A2 Method for detecting anti-transglutaminase antibodies in a saliva sample
03/14/2007EP1761772A1 New intravenous drug administration and blood sampling model in the awake rat
03/14/2007EP1761771A1 Cartridge and sensor-dispensing instrument
03/14/2007EP1761770A1 Dispenser for flattened articles such as diagnostic test strips
03/14/2007EP1761769A1 Tagged resin, method of making a tagged resin, and articles made therefrom
03/14/2007EP1761768A1 Method for determining the authenticity of materials by means of substances which are isotopically marked with oxygen 18
03/14/2007EP1761766A1 Combined ultrasonic imaging and spectroscopic molecular analysis
03/14/2007EP1761765A2 Composition and electrochemical sensor for detecting ischaemia
03/14/2007EP1761763A1 System and method for quality assurance of a biosensor test strip
03/14/2007EP1761762A1 Planar-sensor arrangement, sensor array and method for the production of a planar-sensor arrangement
03/14/2007EP1761761A1 Process and device for emulating a counter-electrode in a monolithically integrated electrochemical analysis system
03/14/2007EP1761757A1 Device for collecting blood and separating blood constituents, method for separating blood constituents and use of said device
03/14/2007EP1761641A2 Device and method for detecting molecular interactions
03/14/2007EP1761631A1 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation
03/14/2007EP1761629A2 Modulation of wrn-mediated telomere-initiated cell signaling